Conflict of interest: The authors declare no conflict of interests.
Applied Cellular Physiology and Metabolic Engineering
Integrated approach to produce a recombinant, his-tagged human α-galactosidase a in mammalian cells†
Article first published online: 25 MAY 2011
DOI: 10.1002/btpr.637
Copyright © 2011 American Institute of Chemical Engineers (AIChE)
Additional Information
How to Cite
Corchero, J. L., Mendoza, R., Lorenzo, J., Rodríguez-Sureda, V., Domínguez, C., Vázquez, E., Ferrer-Miralles, N. and Villaverde, A. (2011), Integrated approach to produce a recombinant, his-tagged human α-galactosidase a in mammalian cells. Biotechnol Progress, 27: 1206–1217. doi: 10.1002/btpr.637
- †
Publication History
- Issue published online: 10 OCT 2011
- Article first published online: 25 MAY 2011
- Accepted manuscript online: 26 APR 2011 10:28AM EST
- Manuscript Revised: 16 FEB 2011
- Manuscript Received: 25 MAY 2010
Funded by
- MICINN. Grant Number: EUI2008-03610
- ERANET-IB 08-007 project
- AGAUR. Grant Number: 2009SGR-108
- Fundació Marató TV3
- VI National R&D&i Plan 2008–2011
- Iniciativa Ingenio 2010
- Consolider Program, CIBER Actions
- Instituto de Salud Carlos III with assistance from the European Regional Development Fund
- Abstract
- Article
- References
- Cited By
Keywords:
- human α-galactosidase A;
- Fabry's disease;
- recombinant protein;
- transient gene expression;
- mammalian cells
Abstract
Successful production of recombinant proteins (r-proteins) by transient gene expression (TGE) depends on several parameters (including producer cells, culture conditions, transfection procedure, or expression vector) that should be optimized when producing any recombinant product. In this work, TGE-based production of human α-galactosidase A (GLA) is described. Producer cells, expression vectors, and parameters influencing cell metabolism after transfection have been tested. The enzyme is secreted, has the right molecular weight, and is enzymatically active. Productivities of up to 30–40 mg/L have been achieved, with a simple, fast procedure. A 6 × His tag allows enzyme purification in a single step, rendering a highly pure product. We propose a TGE-based protocol able to produce up to several milligrams per liter of highly pure, active GLA in a time as short as a few days. By this, enough amounts of engineered versions of the enzyme can be easily produced to be tested in vitro or in preclinical trials. © 2011 American Institute of Chemical Engineers Biotechnol. Prog., 2011

1520-6033/asset/BTPR_left.gif?v=1&s=a5be2ff5a0fe6ccdaad74a6d128c142e5f71a8da)
1520-6033/asset/BTPR_right.gif?v=1&s=992d113a3e61fc9d3571812359165df86cf830e4)
